O'Shaughnessy Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Other funds holding IONS
O'Shaughnessy Asset Management's IONS Position: Q3 2026 in Review
O'Shaughnessy Asset Management sold out of Ionis Pharmaceuticals (IONS) in Q3 2026, closing a stake of 7,166 shares — an estimated $568K sold.
O'Shaughnessy Asset Management first reported a position in IONS in Q4 2019 and held it in 12 quarters. The position peaked at $577K in Q1 2026. 465 funds tracked by Wall St. Rank hold IONS as of Q3 2026.
- O'Shaughnessy Asset Management reported no remaining Ionis Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
- O'Shaughnessy Asset Management sold 7,166 Ionis Pharmaceuticals shares in Q3 2026, an estimated $568K.
- O'Shaughnessy Asset Management first reported a position in Ionis Pharmaceuticals in Q4 2019 and held it in 12 quarters.
- O'Shaughnessy Asset Management's Ionis Pharmaceuticals position peaked at $577K in Q1 2026.
- 465 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.
Based on O'Shaughnessy Asset Management's 13F filing for Q3 2026, filed 12 Nov 2026.